Medicine and Dentistry
Amikacin
100%
Minocycline
87%
Growth
62%
Serratia
37%
Drug
37%
Chemotherapeutic Agent
37%
In Vitro
25%
Pneumonia
25%
Serratia marcescens
25%
Cells
25%
Hospital
25%
Escherichia coli
12%
Incubation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
100%
Minocycline
87%
Pseudomonas aeruginosa
37%
Serratia
37%
Drug
37%
Gram Negative Bacterium
25%
Pneumonia
25%
Serratia marcescens
25%
Synergism
25%
Escherichia coli
12%
Immunology and Microbiology
Growth
62%
Experiment
50%
Serratia
37%
Dilution
37%
Pseudomonas aeruginosa
37%
Gram-Negative Bacteria
25%
Minimum Inhibitory Concentration
25%
Serratia marcescens
25%
Cells
25%
Fractional Inhibitory Concentration Index
25%
Escherichia coli
12%